The backbone of biopharmaceutical drug development, the Biologic Excipients Market is experiencing robust growth. According to a recent analysis by Future Market Insights (FMI), the market is projected to reach a significant USD 2,241.8 million by 2034, with a steady Compound Annual Growth Rate (CAGR) of 4.10% over the next decade. This builds on a strong …